Coronavirus Disease 2019 (COVID-19) Vaccine Prioritization in Low- and Middle-Income Countries May Justifiably Depart From High-Income Countries' Age Priorities

Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S93-S97. doi: 10.1093/cid/ciac398.

Abstract

In high-income countries that were first to roll out coronavirus disease 2019 (COVID-19) vaccines, older adults have thus far usually been prioritized for these vaccines over younger adults. Age-based priority primarily resulted from interpreting evidence available at the time, which indicated that vaccinating the elderly first would minimize COVID-19 deaths and hospitalizations. The World Health Organization counsels a similar approach for all countries. This paper argues that some low- and middle-income countries that are short of COVID-19 vaccine doses might be justified in revising this approach and instead prioritizing certain younger persons when allocating current vaccines or future variant-specific vaccines.

Keywords: COVID-19; age-based prioritization; developing countries; healthcare rationing; vaccines.

MeSH terms

  • Aged
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Developed Countries
  • Developing Countries
  • Humans
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines